Efficacy and safety of a new formulation kit (shampoo + lotion) containing anti‐inflammatory and antioxidant agents to treat hair loss

Androgenetic alopecia (AGA) and telogen effluvium (TE) are common causes of hair loss, with limited options for treatment. The aim of this study was to determine the efficacy and safety of a new formulation kit (Pielus Anti‐hair loss lotion and shampoo) containing anti‐inflammatory and antioxidant a...

Full description

Saved in:
Bibliographic Details
Published in:Dermatologic therapy 2020-05, Vol.33 (3), p.e13293-n/a
Main Authors: Anzai, Alessandra, Pereira, Amanda F., Malaquias, Kleber R., Guerra, Lucas O., Mercuri, Maurízio
Format: Article
Language:English
Subjects:
Adult
alopecia
Alopecia - diagnosis
Alopecia - drug therapy
Alopecia Areata
Anti-Inflammatory Agents - adverse effects
Antioxidants - adverse effects
Female
Hair
hair disorders
Humans
Male
Prospective Studies
therapy—topical
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Androgenetic alopecia (AGA) and telogen effluvium (TE) are common causes of hair loss, with limited options for treatment. The aim of this study was to determine the efficacy and safety of a new formulation kit (Pielus Anti‐hair loss lotion and shampoo) containing anti‐inflammatory and antioxidant agents in patients with TE and/or AGA. This was a prospective, single‐arm, open‐label study with 35 women and 10 men, median age of 44 years, with clinical diagnosis of TE and/or AGA. They used the combination of shampoo and lotion daily for 90 days. There was nonoccurrence of adverse events. Phototricogram showed increase in the average number of anagen hairs at T90 (P
ISSN:1396-0296
1529-8019
DOI:10.1111/dth.13293